The Brief
What Veracyte Decipher AI does
Veracyte Decipher uses AI to analyze genomic profiles of cancer tumors to predict disease aggressiveness and guide treatment decisions. The AI helps avoid over-treatment in low-risk patients and identifies high-risk patients needing aggressive therapy.
Builder’s Brief
Veracyte Decipher AI is a healthcare tool on Falcoscan. AI genomic classifier for cancer treatment decisions. Falcoscan rates Veracyte Decipher AI with an Opportunity score of 86/100, a Saturation score of 6/100, and a Wrapper-risk score of 15/100. Market signal: hot. Veracyte Decipher AI is founded in 2008, currently at Public stage. Pricing: Paid. Rating 4.7/5 across 71 tracked views.